MERAIODE: A Phase II Redifferentiation Trial with Trametinib and I-131 in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated Thyroid Cancer
Thyroid : official journal of the American Thyroid Association(2023)
摘要
No abstract for a research letter.
更多查看译文
关键词
mutated differentiated thyroid cancer,phase ii redifferentiation trial
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要